Editorial Board
WEI LI
NIH/NCI/CIP/LEI · China
Editorial leadership for Journal of Tissue Repair and Regeneration ISSN 2640-6403
Research interests
- Antibody Engineering Vaccine Development Cancer Immunotherapy
Biography
- Li Wei received his bachelor degree of applied chemistry in 2009 from Huazhong University of Science and Technology, China.
- Trained as a bioinorganic chemist in Institute of Biomedical Science (IBS), he earned his PhD in chemical biology from Fudan University, China in 2014.
- His PhD work focus on dissecting the underlying mechanisms of metalloproteins and metalloenzymes involved in key physiological and pathological bio-processes, which include redox-tuning metalloenzymes, metal ions homeostasis maintaining regulators and metalloproteins in neurodegenerative disease.
- In 2014, He joined Dr. Dimiter Dimitrov's group at National Cancer Institute, National Institutes of Health, U.S.A (NIH/NCI) for his postdoctoral training where he study on antibody engineering and vaccine development using combinations of methodologies involving display/screening/library, protein biochemistry, structural biology and computational biology as well as virology, immunology.
- His research field covers the development of useful antibody therapeutics and vaccines against cancer, HIV-1 and emerging and biodefense-related viruses; T Cell Receptor (TCR) engineering to targeting tumor associated antigens or specific antigens; Chimeric Antigen receptor (CAR) engineering; and bispecific antibody design and development.
Considering JTRR for your work?
This journal is guided by WEI LI (NIH/NCI/CIP/LEI) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.